Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395226 · ClinicalTrials.gov registry record · NA
Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial
A NA study, sponsored by Essentia Health.
- Terminated
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT00395226 is a NA study that was terminated before completion, run by Essentia Health. The registered enrollment target is 65 participants.
The verdict
NCT00395226, a NA study, was terminated before completion, sponsored by Essentia Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The signs of rosacea are usually confined to the face, but may appear on the neck, scalp or trunk. Opthalmologic findings are also common. Rosacea is usually described as being most common in fair skinned women over 40. The purpose of the study is to determine whether oral Zinc Sulfate treatment is an effective treatment for facial rosacea.
Interventions
- DRUG placebo
- DRUG zinc sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395226
The ClinicalTrials.gov registry entry for NCT00395226 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essentia Health, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00395226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395226 about?
NCT00395226 is a clinical study titled "Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial". Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The signs of rosacea are usually confined to the face, but may appear on the neck, scalp or trunk. Opthalm...
What is the current status of trial NCT00395226?
This trial is currently terminated. It is a NA study. The enrollment target is 65 participants. The study started on 2006-07. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00395226?
The interventions under investigation include: placebo (DRUG), zinc sulfate (DRUG).
Who is sponsoring clinical trial NCT00395226?
This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.